| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Urologic Oncology Section, Surgery Branch, Division of Cancer Treatment [P. A., G. H. W., W. M. L.] and Laboratory of Pathology [M. J. M.], National Cancer Institute, Bethesda, Maryland 20892; and the Laboratory of Immunobiology, National Cancer Institute-Frederick Cancer Research Facility [K. T., H. B., M. L., B. Z.], Division of Cancer Biology and Diagnosis, National Cancer Institute, Frederick, Maryland 21701
Renal cell carcinoma has been characterized by an abnormality on the short arm of chromosome 3 which suggests the presence of a tumor suppressor gene at this location. In order to more precisely define the location of the renal cell carcinoma gene and to differentiate molecular changes occurring in early stages of renal neoplasia versus those occurring later in malignant progression, DNA from normal and tumor tissue from 60 patients with various stages of renal cell carcinoma was analyzed for loss of alleles at different chromosomal loci. In tumor tissue from 51 of 58 evaluable patients (88%) there was loss of heterozygosity at one or more of 10 loci tested on chromosome 3 independently of tumor stage. Analysis of the genotypes identified the distal portion of 3p bounded by D3S2 and D3S22 (3p21-26) as the region of the disease gene. In tumor tissue from patients with advanced renal cell carcinoma, we found loss of heterozygosity on chromosome 11p in 5 of 21 (24%), on chromosome 13 in 3 of 9 (33%), and on chromosome 17 in 2 of 19 (11%). We found no loss of heterozygosity at the loci on chromosomes 11, 13, or 17 in tumor tissue from patients with localized renal cell carcinoma (N = 5). These data suggest the existence of a tumor suppressor gene on chromosome 3p which may be essential to the genesis of sporadic renal cell carcinoma and that other tumor suppressor genes are associated with progression of this malignancy.
1 To whom requests for reprints should be addressed, at Urologic Oncology Section, Surgery Branch, National Cancer Institute, Bldg. 10, Room 2B47, Bethesda, MD 20892.
Received 9/ 7/90. Accepted 11/19/90.
This article has been cited by other articles:
|
|
 |
|
  U. H. Frey, G. Lummen, T. Jager, K.-H. Jockel, K. W. Schmid, H. Rubben, N. Muller, W. Siffert, and A. Eisenhardt The GNAS1 T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma Clin. Cancer Res., February 1, 2006; 12(3): 759 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Pantuck, G. Zeng, A. S. Belldegrun, and R. A. Figlin Pathobiology, Prognosis, and Targeted Therapy for Renal Cell Carcinoma: Exploiting the Hypoxia-Induced Pathway Clin. Cancer Res., October 15, 2003; 9(13): 4641 - 4652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G S Nouman, J J Anderson, J Lunec, and B Angus The role of the tumour suppressor p33ING1b in human neoplasia J. Clin. Pathol., July 1, 2003; 56(7): 491 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yang, M. Kost-Alimova, S. Ingvarsson, Q. Qianhui, H. Kiss, A. Szeles, I. Kholodnyuk, A. Cuthbert, G. Klein, and S. Imreh Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice PNAS, January 30, 2001; 98(3): 1136 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Jiang, R. Desper, C. H. Papadimitriou, A. A. Schäffer, O.-P. Kallioniemi, J. Richter, P. Schraml, G. Sauter, M. J. Mihatsch, and H. Moch Construction of Evolutionary Tree Models for Renal Cell Carcinoma from Comparative Genomic Hybridization Data Cancer Res., November 1, 2000; 60(22): 6503 - 6509. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Shen, Z. Zhuang, D. J. Gersell, and F. A. Tavassoli Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients International Journal of Surgical Pathology, July 1, 2000; 8(3): 207 - 212. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Jiang, J. Richter, P. Schraml, L. Bubendorf, T. Gasser, G. Sauter, M. J. Mihatsch, and H. Moch Chromosomal Imbalances in Papillary Renal Cell Carcinoma : Genetic Differences between Histological Subtypes Am. J. Pathol., November 1, 1998; 153(5): 1467 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Lubensky, S. Pack, D. Ault, A. O. Vortmeyer, S. K. Libutti, P. L. Choyke, M. M. Walther, W. M. Linehan, and Z. Zhuang Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients : Histopathological and Molecular Genetic Analysis Am. J. Pathol., July 1, 1998; 153(1): 223 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Motzer, N. H. Bander, and D. M. Nanus Renal-Cell Carcinoma N. Engl. J. Med., September 19, 1996; 335(12): 865 - 875. [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Linehan, M. I. Lerman, and B. Zbar Identification of the von Hippel-Lindau (VHL) Gene: Its Role in Renal Cancer JAMA, February 15, 1995; 273(7): 564 - 570. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
